Jeff Lightfoot

1.1k total citations
15 papers, 925 citations indexed

About

Jeff Lightfoot is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Jeff Lightfoot has authored 15 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Hematology and 3 papers in Genetics. Recurrent topics in Jeff Lightfoot's work include DNA Repair Mechanisms (5 papers), Acute Myeloid Leukemia Research (2 papers) and Dermatology and Skin Diseases (2 papers). Jeff Lightfoot is often cited by papers focused on DNA Repair Mechanisms (5 papers), Acute Myeloid Leukemia Research (2 papers) and Dermatology and Skin Diseases (2 papers). Jeff Lightfoot collaborates with scholars based in Canada, United States and Australia. Jeff Lightfoot's co-authors include Manuel Buchwald, Robert C. Cumming, Hagop Youssoufian, Peter J. O’Brien, K Beard, Lucine Bosnoyan-Collins, Jan C. Pronk, Carola G.M. van Berkel, Martin A. Rooimans and Noa Alon and has published in prestigious journals such as Nature Medicine, Nature Genetics and Blood.

In The Last Decade

Jeff Lightfoot

14 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeff Lightfoot Canada	10	728	279	150	141	119	15	925
Jan de Groot Netherlands	13	560 0.8×	163 0.6×	112 0.7×	99 0.7×	93 0.8×	23	705
Françoise Hoffschir France	21	842 1.2×	215 0.8×	129 0.9×	135 1.0×	40 0.3×	30	1.1k
Mads H. Haugen Norway	18	856 1.2×	320 1.1×	91 0.6×	227 1.6×	132 1.1×	40	1.2k
Mounira Amor-Guéret France	21	1.1k 1.6×	265 0.9×	128 0.9×	260 1.8×	119 1.0×	42	1.3k
Anderson T. Wang United Kingdom	11	778 1.1×	191 0.7×	101 0.7×	229 1.6×	28 0.2×	16	911
Ding-Yen Lin Taiwan	11	702 1.0×	115 0.4×	138 0.9×	170 1.2×	102 0.9×	15	854
Carol Reifsteck United States	16	1.3k 1.8×	472 1.7×	260 1.7×	197 1.4×	75 0.6×	19	1.5k
Sara Rodríguez‐Acebes Spain	18	989 1.4×	189 0.7×	153 1.0×	302 2.1×	54 0.5×	27	1.2k
Lipeng Wu China	13	1.1k 1.5×	126 0.5×	104 0.7×	208 1.5×	81 0.7×	15	1.3k
Zhanwen Du United States	13	712 1.0×	258 0.9×	93 0.6×	130 0.9×	87 0.7×	17	867

Countries citing papers authored by Jeff Lightfoot

Since Specialization

Citations

This map shows the geographic impact of Jeff Lightfoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Lightfoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Lightfoot more than expected).

Fields of papers citing papers by Jeff Lightfoot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Lightfoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Lightfoot. The network helps show where Jeff Lightfoot may publish in the future.

Co-authorship network of co-authors of Jeff Lightfoot

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Lightfoot. A scholar is included among the top collaborators of Jeff Lightfoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Lightfoot. Jeff Lightfoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Upadhayaya, Ram Shankar, et al.. (2016). Discovery of Selective Dual Inhibitors of Bromodomain Protein BRD4 and JAK2 for Treatment of Hematologic Malignancies. Blood. 128(22). 5212–5212. 1 indexed citations

Zhang, Hongying, Andrea Local, Khalid Benbatoul, et al.. (2016). Inhibition of c-Myc By Apto-253 As an Innovative Therapeutic Approach to Induce Cell Cycle Arrest and Apoptosis in Acute Myeloid Leukemia. Blood. 128(22). 1716–1716. 3 indexed citations

Rice, William G., Jeff Lightfoot, Hongying Zhang, et al.. (2015). Clinical Pharmacokinetics of Apto-253 Support Its Use As a Novel Agent for the Treatment of Relapsed or Refractory Hematologic Malignancies. Blood. 126(23). 4934–4934. 1 indexed citations

Rice, William G., Yoon Lee, Jeff Lightfoot, et al.. (2014). APTO-253 Induces KLF4 to Promote Potent in Vitro Pro-Apoptotic Activity in Hematologic Cancer Cell Lines and Antitumor Efficacy As a Single Agent and in Combination with Azacitidine in Animal Models of Acute Myelogenous Leukemia (AML). Blood. 124(21). 4813–4813. 3 indexed citations

Ferdinandi, Eckhardt S., Aikaterini Vassilakos, Yoon Lee, et al.. (2010). Preclinical toxicity and toxicokinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase R2. Cancer Chemotherapy and Pharmacology. 68(1). 193–205. 9 indexed citations

Lightfoot, Jeff. (2010). The ‘Pacific’ President's agenda forTransatlantica. Journal of Transatlantic Studies. 8(3). 290–300.

Benatar, Tania, Ming Cao, Yoon Lee, et al.. (2009). IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo. Cancer Immunology Immunotherapy. 59(6). 805–817. 83 indexed citations

Benatar, Tania, Ming Cao, Youn‐Bok Lee, et al.. (2008). Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors. Cancer Immunology Immunotherapy. 57(12). 1757–1769. 43 indexed citations

Al‐Qawasmeh, Raed A., Yoon Lee, Xiaoping Gu, et al.. (2008). 11-Phenyl-[b,e]-dibenzazepine compounds: Novel antitumor agents. Bioorganic & Medicinal Chemistry Letters. 19(1). 104–107. 25 indexed citations

10.

Li, Hui, Ming Cao, Yoon Lee, et al.. (2007). Virulizin®, a novel immunotherapy agent, stimulates TNFα expression in monocytes/macrophages in vitro and in vivo. International Immunopharmacology. 7(10). 1350–1359. 9 indexed citations

11.

Cumming, Robert C., Jeff Lightfoot, K Beard, et al.. (2001). Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nature Medicine. 7(7). 814–820. 196 indexed citations

12.

Winter, Johan P. de, France Léveillé, Carola G.M. van Berkel, et al.. (2000). Isolation of a cDNA Representing the Fanconi Anemia Complementation Group E Gene. The American Journal of Human Genetics. 67(5). 1306–1308. 175 indexed citations

13.

Winter, Johan P. de, Carola G.M. van Berkel, Martin A. Rooimans, et al.. (2000). Isolation of a cDNA Representing the Fanconi Anemia Complementation Group E Gene. The American Journal of Human Genetics. 67(5). 1306–1308. 9 indexed citations

14.

Foe, Jerome R. Lo Ten, Martin A. Rooimans, Lucine Bosnoyan-Collins, et al.. (1996). Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nature Genetics. 14(3). 320–323. 355 indexed citations

15.

Ouellet, Catherine, Marie‐Josée Morency, Ken Dewar, et al.. (1996). Physical mapping of 32 genetic markers on the Pseudomonas aeruginosa PAO1 chromosome. Microbiology. 142(1). 79–86. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact